INTRODUCTION
Laboratory investigations of patients with primary immunodeficiency have provided useful insights into the functioning of the human immune system. Key among these is the recent appreciation that such disorders may not all be caused by an intrinsic inability of stem cells to fully differentiate into mature lymphoid cells (1) (2) (3) (4) . In some forms of immunoglobulin deficiency, apparently mature bursa-equivalent (B) lymphocytes are present in normal numbers (2) . In a number of such patients, excessive suppressive activity of nonbursa-equivalent cell populations has been demonstrated, raising the question of an etiological role for such cells in the pathogenesis of these conditions (3) .
Among these are common variable agammaglobulinemia (4) (5) (6) , hypogammaglobulinemia with benign thymoma (5, 7) , some cases of selective Immunoglobulin (Ig)A deficiency (8) , and the hypogammaglobulinemia accompanying multiple myeloma (9, 10) . There is also some preliminary evidence to suggest that certain patients with x-linked agammaglobulinemia may have excessive suppressor cell activity (11, 12) .
The development of assays with cultured human peripheral blood mononuclear cells stimulated with pokeweed mitogen has made it possible to begin to probe into some ofthe regulatory mechanisms involved in the activation of B lymphocytes for immunoglobulin synthesis and secretion (4, 13, 14) . One such recently described procedure, the plaque-forming cell assay (15) , has considerable potential for evaluating not only the intrinsic capacity of B lymphocytes to differentiate into antibody-forming cells, but also the roles of both suppressor and helper cells in the induction of antibody synthesis. In the studies reported here, we used this assay to study B-cell activation in patients with welldefined primary immunodeficiency disorders and compared its usefulness with that of the immunoglobulin biosynthesis assay described by Waldmann et al. (4) . Our results show that the plaque-forming cell assay is capable of detecting excessive suppressor cell activity in these patients and that, for this purpose, it is comparable to the immunoglobulin biosynthetic assay. In addition, it has the added advantage of allowing measurement of specific IgM antibody-forming capacity in these patients.
METHODS
Patient population. This consisted of 24 patients with well-defined primary immunodeficiency diseases (16) Boyum (18) , as previously described (19) .
Fractionation ofmononuclear cells. In some assays FicollHypaque-isolated, peripheral blood mononuclear cells were separated into thymus-derived (T) lymphocyte enriched, T-cell depleted (non-T), or monocyte-depleted (nonadherent) populations. Equal volumes of mononuclear cells (2-4 x 106/ ml) and a 2% suspension of neuraminidase-treated sheep erythrocytes (SRBC)1 (20) were mixed in 15-or 50-ml centrifuge tubes, centrifuged for 5 min at 200 g at room temperature, and incubated for 1 h at room temperature. 
RESULTS
Culture conditions. Experiments were undertaken to determine optimal conditions for the plaque assay. As has been reported, the peak plaque-forming cell response after pokeweed mitogen stimulation occurred on days 5 and 6 (15) . Few plaques were detected before day 4 and the number had fallen off sharply by day 7.
The optimal concentration of mononuclear cells placed in culture was also determined. Fig. 2 depicts the results ofthese experiments. Whereas T cell-depleted populations lacked plaque-forming cells, the T cell-enriched populations did produce some plaque-forming cells in three of seven experiments. When T cell-enriched populations were added to T cell-depleted populations, the plaque-forming cell response was restored toward normal.
Detection of suppression in co-cultures. To determine whether the plaque-forming cell assay could detect the presence of excessive suppressor cell activity, co-cultures were made of mononuclear cells from normal individuals and patients with immunodeficiencies. Tables II and III present the results of studies in which mononuclear cells from various normal individuals were co-cultured with those from other normals, from 15 patients with common variable agammaglobulinemia, from 7 with x-linked agammaglobulinemia and from 2 with hyper-IgM. In 11 co-cultures of cells from different normal individuals, the observed number of plaques was 62-150% of the predicted number, with the mean being 86% of predicted (Table II) .
Co-cultures of cells from normal controls and from 8 of 15 common variable agammaglobulinemic patients gave plaque-forming cell assay results that were on the average 106% ofpredicted (range 84-180%) (Table III) There was also evidence for excessive suppressor activity in some of the patients with x-linked agammaglobulinemia (Table III) . None of these patients' cells made plaque-forming cells when cultured individually (Fig. 1) . In co-cultures of mononuclear cells from normal individuals with cells from patients 1, 2, and 3 there was 100, 100, and 68% suppression, respectively, in the plaque-forming cell assay. showing evidence of increased suppressor cell activity are of particular interest because they were each afflicted with persistent enterovirus infections of the central nervous system (26) , whereas the patients who did not suppress did not have such infections.
Co-cultures of mononuclear cells from normal controls and from the two patients with hyper-IgM showed no plaque formation at all (Table III) , indicating complete suppression. Cells from each of these patients also suppressed IgM biosynthesis by -70%.
Cellular requirements for suppression. A series of studies was conducted to determine if the cellular suppression noted was the property ofa specific subpopulation of lymphocytes. We studied SRBC rosetting (T) cells and mononuclear cells depleted of SRBC rosetting cells (non-T) from five of the seven patients with common variable agammaglobulinemia whose unfractionated mononuclear cells had demonstrated excessive suppressor activity. The results of a typical study are shown in Fig. 3 . Patient T cells, but not patient non-T cells, were capable of suppressing almost completely the expected number of plaque-forming cells when cocultured with normal unfractionated mononuclear cells. Non-T cells from the patient and T cells from a normal individual were incapable of producing plaques when cultured alone. In contrast, non-T (i.e., B cell-enriched) cells from this patient were able to produce a large number of plaques when cultured with purified normal T cells. These results were typical of results from three more of the five patients studied. The fifth patient's T-depleted cells did not produce plaques when cultured with normal T cells. Cells from two patients whose unfractionated cells did not suppress in co-cultures with normal cells were also separated and evaluated in a similar manner. In both instances their non-T cells failed to produce plaques when co-cultured with normal T cells. Finally, purified monocytes from two patients with common variable agammaglobulinemia whose unfractionated mononuclear cells suppressed normal plaque-forming cell capacity were isolated as described. Addition of the nonadherent fraction to normal unfractionated mononuclear cells gave the expected suppressions. Adherent cells recovered and washed were added in varying numbers to unfractionated normal cells. These adherent cells failed to cause any suppression. The results of one of these experiments are shown in Fig. 4 .
DNA synthetic response to pokeweed mitogen. A possible explanation for the failure of cells from the immunodeficiency patients to produce plaques is that cells from such patients are incapable of giving a blastogenic response to pokeweed mitogen. Table IV indicates that cells from all patients studied did undergo significant DNA synthesis in the presence of pokeweed mitogen.
DISCUSSION
The studies detailed here confirm recent reports from other laboratories that a proportion ofhuman peripheral blood mononuclear cells can be induced to become hemolytic plaque-forming cells in vitro (14, 15, 23, 28, 29) . For years assays of this type have proven of immense value in studying the in vitro antibody-forming capacity of single lymphoid cells from experimental animals (27) . Their availability now for the study of human primary immunodeficiency disorders provides a new probe to examine the cellular nature of such defects, because it allows in vitro measurement of specific IgM antibody-forming capacity. Other currently available methods for studying human B-cell activation in vitro, those measuring immunoglobulin synthesis and secretion (4, 30) or allowing enumeration of cells with intracytoplasmic immunoglobulin (5, 7, 13) , are limited in their usefulness, as they do not measure specific antibody production. In the present report, a good correlation was noted in co-culture studies when the plaque-forming cell assay was compared with the immunoglobulin biosynthesis assay for its ability to detect excessive suppressor cell activity in immunodeficient patients. This indicates the additional potential usefulness of the plaque-forming cell assay in the study of cell-cell interactions in immunodeficient and other patient populations.
The results of our studies of in vitro IgM biosynthesis and IgM anti-SRBC production in the immunodeficient patient population studied are in general agreement with the findings of others who have studied immunoglobulin synthesis in immunodeficient patients. Most patients with common variable and all patients with xlinked agammaglobulinemia have been found incapable of synthesizing significant quantities of immunoglobulin in vitro when their blood cells were stimulated with the polyclonal B-cell activator, pokeweed mitogen (3-7, 11, 13, 31 suppressor cell activity by either assay were separated into T-enriched and Tdepleted populations. The T-enriched fractions still failed to suppress normal cell plaque formation and the T-depleted populations failed to produce IgM anti-SRBC antibody when co-cultured with normal T cells. The latter findings suggest, as hypothesized by others (31) , that an intrinsic B cell defect exists in such patients.
The role or roles of excessive T suppressor cell activity in patients with humoral immunodeficiency remains unclear. Perhaps the most convincing evidence that suppressor T cells may have a role in the genesis of the immunodeficiency comes from cell separation studies done by Waldmann et al. (11) and from studies in the present report showing that, for certain common variable agammaglobulinemics, removal of the patient's own T cells allowed his B cells to synthesize immunoglobulin or to form plaques. Neither of these studies excluded the possibility of a primary T helper cell defect, however. Against a primary role for excessive suppressor cell activity in these defects are the observations from the present study that (a) cells from only one ofidentical twins with common variable agammaglobulinemia caused significant suppression of IgM biosynthesis or plaque formation by normal cells, (b) that three of seven patients with x-linked agammaglobulinemia who lacked surface immunoglobulin positive B cells had excessive suppressive cell activity, and (c) that cells from both patients with x-linked immunodeficiency with hyper-IgM caused significant suppression of normal B-cell activation in both assays. In all of these latter situations, it would seem most likely that the increased suppressor cell activity develops secondarily to whatever the primary biologic defects are in such patients.
The factor or factors leading to development of increased suppressor cell activity are unknown. Recently it has been suggested that aggregated gamma globulin present in intramuscular immune serum globulin preparations could interact with the Fc receptor for IgG present on suppressor T cells, stimulating them for increased activity (33) . This does not appear to be a likely explanation for the heterogeneity seen in the present study, because as many patients received plasma or the experimental intravenous immune serum globulin preparation as received intramuscular gamma globulin among those exhibiting increased suppressor cell activity. Infection is another possible factor leading to generation of increased suppressor cell activity. In this regard, it is of note that all three patients with xlinked agammaglobulinemia exhibiting this activity had persistent echovirus meningoencephalitis, whereas those not exhibiting it did not. Whether this increased suppressor activity contributed in any way to the patients' inability to get rid ofthe virus is unknown.
